Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis
NCT03289351
Appendicitis, Cecal Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT Number: NCT00677417
The values of laboratory examinations which are useful for the diagnoses of appendicitis are white blood cell count (WBC), C-reactive protein (CRP) and erythrocyte blood sedimentation rate (ESR). However up to date there is no laboratory marker for the pre-operative diagnosis of appendiceal perforation in acute appendicitis. Recently hyperbilirubinaemia has been associated with appendiceal perforation. Aim of this retrospective study is therefore to investigate if hyperbilirubinaemia has a diagnostic value for the pre-operative diagnosis of appendiceal perforation in patients with appendicitis.
Looking for future studies?
Notify MeAll sexes
Observational
We identified 538 patients with histologically proved acute appendicitis who underwent laparoscopic or conventional appendicectomy between January, 2004 and December, 2007 in a surgical department of an academic teaching hospital. A retrospective multiple chart review of the medical records including laboratory values (bilirubin, CRP, white blood count) and histological results was conducted.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ruhr University of Bochum
Other
A Retrospective Study Investigating the Diagnostic Value of Hyperbilirubinaemia as a Predictive Factor for Appendiceal Perforation in Acute Appendicitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03289351
Appendicitis, Cecal Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03159754
Appendicitis, Cecal Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT04512196
Appendicitis, Cecal Diseases
Kota Kinabalu, Sabah, Malaysia
View Trial DetailsNCT02724410
Appendicitis, Cecal Diseases
View Trial Details